Clinical Trial Update: Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of delgocitinib cream in adolescents aged 12-17 with moderate to severe chronic hand eczema. Results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Dermatitis
• Hand Eczema

Drugs mentioned

• Delgocitinib Cream (delgocitinib)

Snippet

Sponsor: LEO Pharma | Conditions: Chronic Hand Eczema | Phase 3 | Status: COMPLETED | Results posted: 2025-07-02